Diabetes and Obesity in Pregnancy: From Patients to Molecular Mechanisms

Author(s): Luis Sobrevia*

Journal Name: Current Vascular Pharmacology

Volume 19 , Issue 2 , 2021

Become EABM
Become Reviewer
Call for Editor

Fowden AL, Camm EJ, Sferruzzi-Perri AN. Effects of maternal obesity on placental phenotype. Curr Vasc Pharmacol 2021; 19(2): 113-31.
Mate A, Reyes-Goya C, Santana-Garrido Á, Vázquez CM. Lifestyle, maternal nutrition and healthy pregnancy. Curr Vasc Pharmacol 2021; 19(2): 132-40.
Szlapinski SK, Hill DJ. Metabolic adaptations to pregnancy in healthy and gestational diabetic pregnancies: the pancreas -placenta axis. Curr Vasc Pharmacol 2021; 19(2): 141-53.
Poblete JA, Olmos P. Obesity and gestational diabetes in pregnant care and clinical practice. Curr Vasc Pharmacol 2021; 19(2): 154-64.
Murthi P, Rajaraman G. Inflammasomes in the pathophysiology of maternal obesity: potential therapeutic targets to reduce long-term adverse health outcomes in the mother and offspring. Curr Vasc Pharmacol 2021; 19(2): 165-55.
Bedell S, Hutson J, de Vrijer B, Eastabrook G. Effects of maternal obesity and gestational diabetes mellitus on the placenta: current knowledge and targets for therapeutic interventions. Curr Vasc Pharmacol 2021; 19(2): 176-92.
Carvajal JA, Oporto JI. The myometrium in pregnant women with obesity. Curr Vasc Pharmacol 2021; 19(2): 193-200.
Lorenzon AR, Moreli JB, de Macedo Melo R, et al. Stromal cell-derived factor (SDF) 2 and the endoplasmic reticulum stress response of trophoblast cells in gestational diabetes mellitus and in vitro hyperglycaemic condition. Curr Vasc Pharmacol 2021; 19(2): 201-9.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2021
Published on: 29 December, 2020
Page: [111 - 112]
Pages: 2
DOI: 10.2174/157016111902201230093444

Article Metrics

PDF: 22